Literature DB >> 15015179

Bisphosphonates and bone necrosis.

M Anthony Pogrel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15015179     DOI： 10.1016/j.joms.2003.11.003

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN： 0278-2391            Impact factor:   1.895


× No keyword cloud information.
  8 in total

1.  Accumulation of p100, a precursor of NF-κB2, enhances osteoblastic differentiation in vitro and bone formation in vivo in aly/aly mice.

Authors:  Yoshinori Seo; Hidefumi Fukushima; Toshimasa Maruyama; Kayoko Nakao Kuroishi; Kenji Osawa; Kenichi Nagano; Kazuhiro Aoki; Falk Weih; Takahiro Doi; Min Zhang; Keiichi Ohya; Takenobu Katagiri; Ryuji Hosokawa; Eijiro Jimi
Journal:  Mol Endocrinol       Date:  2012-01-26

Review 2.  Potential pathophysiological mechanisms in osteonecrosis of the jaw.

Authors:  Regina Landesberg; Victoria Woo; Serge Cremers; Matthew Cozin; Darja Marolt; Gordana Vunjak-Novakovic; Stavroula Kousteni; Srikala Raghavan
Journal:  Ann N Y Acad Sci       Date:  2011-02       Impact factor: 5.691

3.  [Bisphosphonates and osteonecrosis of the jaw].

Authors:  I Schirmer; H Peters; P A Reichart; H Dürkop
Journal:  Mund Kiefer Gesichtschir       Date:  2005-07

Review 4.  Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review.

Authors:  Larissa Fernandes Silva; Cláudia Curra; Marcelo Salles Munerato; Carlos Cesar Deantoni; Mariza Akemi Matsumoto; Camila Lopes Cardoso; Marcos Martins Curi
Journal:  Oral Maxillofac Surg       Date:  2015-12-11

5.  Inhibition of oral mucosal cell wound healing by bisphosphonates.

Authors:  Regina Landesberg; Matthew Cozin; Serge Cremers; Victoria Woo; Stavroula Kousteni; Satrajit Sinha; LeeAnn Garrett-Sinha; Srikala Raghavan
Journal:  J Oral Maxillofac Surg       Date:  2008-05       Impact factor: 1.895

6.  Imaging findings in bisphosphonate-induced osteonecrosis of the jaws.

Authors:  Katarina Surlan Popovic; Miha Kocar
Journal:  Radiol Oncol       Date:  2010-06-24       Impact factor: 2.991

Review 7.  Tolerability of different dosing regimens of bisphosphonates for the treatment of osteoporosis and malignant bone disease.

Authors:  Raja S Bobba; Karen Beattie; Bill Parkinson; Dinesh Kumbhare; Jonathan D Adachi
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

Review 8.  Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw.

Authors:  Lina He; Xiangyu Sun; Zhijie Liu; Yanfen Qiu; Yumei Niu
Journal:  Int J Oral Sci       Date:  2020-10-21       Impact factor: 6.344
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.